NCT04729218

Brief Summary

Motor imagery is the mental representation of movement without any doing body movement. A main function of imagery is to aid the self-regulation of thoughts, feelings, and behaviours. Studies have shown to be more effective for individuals displaying a higher level of imagery ability when using imagery to improve motor and motivational outcomes, including self-efficacy. The aim of this study is to measure the movement imagery ability in patients with Familial Mediterranean Fever and compare it with healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

January 24, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

January 28, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 13, 2021

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 18, 2021

Completed
Last Updated

August 2, 2022

Status Verified

August 1, 2022

Enrollment Period

3.1 years

First QC Date

January 24, 2021

Last Update Submit

August 1, 2022

Conditions

Keywords

movement imagery abilitypaincatastrophizingfamilial mediterranean fever

Outcome Measures

Primary Outcomes (1)

  • Movement Imagery Questionnaire-3 (MIQ-3)

    It is a questionnaire containing 12 items to evaluate the visual imagination skills of the individual. It evaluates internal visual imagery, external visual imagery, and kinesthetic imagery. For each item, first of all, individuals read the description of the movement, and then it is desired to perform the movement physically and after that, the same movement is requested. Individuals evaluate the degree of imagination on a 7-point Likert-type scale ranging from 1 (very difficult to see/feel) to 7 (very easy to see/feel). The motion visualization questionnaire has good psychometric properties, internal reliability, and estimated validity.

    Baseline

Secondary Outcomes (2)

  • McGill Melzack Pain Questionnaire (MPQ)

    Baseline

  • Pain Catastrophizing Scale

    Baseline

Study Arms (2)

Familial Mediterranean Fever group

30 participants

Behavioral: movement imagery ability

Healthy group

30 participants

Behavioral: movement imagery ability

Interventions

Determining the movement imagery ability: internal visual, external visual and kinesthetic imagery

Familial Mediterranean Fever groupHealthy group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with Familial Mediterranean Fever and Healthy Controls

You may qualify if:

  • having had at least one attack last year
  • co-operated individuals

You may not qualify if:

  • patients with a neurological disorder,
  • diagnosed with cancer,
  • cognitive impairment,
  • having a primary pathology of the musculoskeletal system,
  • having previous imagery practice,
  • having an additional rheumatic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University, Cerrahpaşa Medical Faculty, Department of Rheumatology

Istanbul, Turkey (Türkiye)

Location

Related Links

MeSH Terms

Conditions

Familial Mediterranean FeverPain

Condition Hierarchy (Ancestors)

Hereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Albina Alikaj, MSc

    Medipol University

    PRINCIPAL INVESTIGATOR
  • Ahsen Büyükaslan, MSc

    Medipol University

    STUDY CHAIR
  • Serdal Uğurlu, Prof

    Istanbul University - Cerrahpasa

    STUDY DIRECTOR
  • Burcu Dilek, PhD

    Acibadem University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 24, 2021

First Posted

January 28, 2021

Study Start

January 1, 2018

Primary Completion

February 13, 2021

Study Completion

February 18, 2021

Last Updated

August 2, 2022

Record last verified: 2022-08

Locations